Reply to 'development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2' by Solimani F et al.
作者信息
Falcinelli F, Lamberti A, Cota C, Rubegni P, Cinotti E
机构信息
Dermatology Unit and Skin Bank, Department of Medical, Surgical and Neurosciences, Siena University Hospital, Siena, Italy.
Dermatopathology Unit, San Gallicano Dermatological Institute, IRCCS, Rome, Italy.
出版信息
J Eur Acad Dermatol Venereol. 2022 Dec;36(12):e976-e978. doi: 10.1111/jdv.18398. Epub 2022 Jul 12.
Abstract
摘要
相似文献
1
Reply to 'development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2' by Solimani F et al.对索利马尼·F等人所著《接种BNT162b2新冠疫苗后发生严重寻常型天疱疮》的回复
J Eur Acad Dermatol Venereol. 2022 Dec;36(12):e976-e978. doi: 10.1111/jdv.18398. Epub 2022 Jul 12.
2
Reply to 'Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2' by Solimani et al.对索利马尼等人所著《接种BNT162b2新冠疫苗后发生重度寻常型天疱疮》的回复
J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e750-e751. doi: 10.1111/jdv.18302. Epub 2022 Jun 17.
3
Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2.接种BNT162b2新冠疫苗后发生重症寻常型天疱疮
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e649-e651. doi: 10.1111/jdv.17480. Epub 2021 Jul 12.
4
Pemphigus vulgaris after SARS-CoV-2 vaccination: A case with new-onset and two cases with severe aggravation.接种 SARS-CoV-2 疫苗后发生寻常型天疱疮：1 例新发，2 例严重恶化。
Dermatol Ther. 2022 May;35(5):e15396. doi: 10.1111/dth.15396. Epub 2022 Mar 15.
5
Immediate reactions after mRNA SARS-CoV-2 vaccination.新型冠状病毒mRNA疫苗接种后的即时反应。
CMAJ. 2021 Dec 6;193(48):E1842. doi: 10.1503/cmaj.211581. Epub 2021 Nov 12.
6
De novo severe pemphigus vulgaris following SARS-CoV-2 vaccination with BBIBP-CorV.接种BBIBP-CorV新冠疫苗后新发重症寻常型天疱疮
Dermatol Ther. 2022 Jun;35(6):e15448. doi: 10.1111/dth.15448. Epub 2022 Mar 20.
7
Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac).接种两剂信使核糖核酸疫苗（BNT162b2）和灭活病毒疫苗（科兴新冠疫苗）后发生的结核病
J Infect. 2023 Mar;86(3):256-308. doi: 10.1016/j.jinf.2022.12.016. Epub 2022 Dec 17.
8
Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases.罕见风湿性疾病患者接种BNT162b2 mRNA新冠疫苗后的安全性及疾病复发低风险
J Rheumatol. 2022 Mar;49(3):334-335. doi: 10.3899/jrheum.210863. Epub 2022 Jan 15.
9
Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study' by Shasha et al.沙莎等人的“辉瑞BNT162b2新冠病毒疫苗的真实世界安全性数据，历史性队列研究”
Clin Microbiol Infect. 2022 Mar;28(3):452-453. doi: 10.1016/j.cmi.2021.11.013. Epub 2021 Nov 25.
10
Prompt onset of Rowell's syndrome following the first BNT162b2 SARS-CoV-2 vaccination.首次接种BNT162b2新冠疫苗后迅速出现罗威尔综合征。
J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e415-e416. doi: 10.1111/jdv.17225. Epub 2021 Apr 19.
引用本文的文献
1
Pemphigus and Bullous Pemphigoid Following COVID-19 Vaccination: A Systematic Review.新型冠状病毒肺炎疫苗接种后的天疱疮和大疱性类天疱疮：一项系统评价
Viruses. 2024 Dec 9;16(12):1896. doi: 10.3390/v16121896.
2
New Onset and Exacerbation of Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Systematic Review.新冠疫苗接种后自身免疫性大疱性皮肤病的新发与加重：一项系统评价
Vaccines (Basel). 2024 Apr 26;12(5):465. doi: 10.3390/vaccines12050465.
3
Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future?常见炎症性皮肤病的远程皮肤病学：未来医学？
Life (Basel). 2023 Apr 18;13(4):1037. doi: 10.3390/life13041037.
4
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review.远程皮肤病学在2019年冠状病毒病大流行期间的作用：一项叙述性综述
Clin Cosmet Investig Dermatol. 2022 Dec 19;15:2785-2793. doi: 10.2147/CCID.S377029. eCollection 2022.
Zotero 插件